Enanta Hopes To Succeed In RSV With N-Protein Inhibition Approach

 
• By Joseph Haas
  
respiratory-syncytial-virus
Efforts to develop a drug therapy for RSV had yielded numerous failures

More from Clinical Trials

More from R&D